Cardiff Oncology, Inc.CRDFNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-37.97M
↓ 44% vs avg
Percentile
P0
Near historical low
Streak
2 yr
Consecutive declineContracting
Average
$-26.35M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-37.97M | -0.5% |
| 2024 | $-37.77M | -20.0% |
| 2023 | $-31.47M | +9.3% |
| 2022 | $-34.71M | -49.3% |
| 2021 | $-23.25M | -40.7% |
| 2020 | $-16.53M | -23.9% |
| 2019 | $-13.34M | -1.0% |
| 2018 | $-13.21M | +43.5% |
| 2017 | $-23.38M | +26.6% |
| 2016 | $-31.86M | - |